What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Mutation
His primary areas of study are Genetics, Internal medicine, Mutation, Myopathy and Cell biology.
Hanns Lochmüller works in the field of Internal medicine, namely Muscular dystrophy.
His biological study spans a wide range of topics, including Limb-girdle muscular dystrophy, Physical therapy and Duchenne muscular dystrophy.
His Mutation research incorporates elements of Phenotype, Genotype and Actin.
His Cell biology study combines topics from a wide range of disciplines, such as Spinal muscular atrophy, Zebrafish and Skeletal muscle.
The concepts of his Gene study are interwoven with issues in Molecular biology and Disease.
His most cited work include:
- The Human Phenotype Ontology in 2017 (471 citations)
- The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. (341 citations)
- Mutations in dynamin 2 cause dominant centronuclear myopathy (337 citations)
What are the main themes of his work throughout his whole career to date?
Hanns Lochmüller mainly investigates Genetics, Internal medicine, Duchenne muscular dystrophy, Pathology and Muscular dystrophy.
Mutation, Gene, Myopathy, Missense mutation and Phenotype are the subjects of his Genetics studies.
Gene and Molecular biology are frequently intertwined in his study.
His research in Internal medicine focuses on subjects like Endocrinology, which are connected to Neuromuscular junction.
Many of his studies involve connections with topics such as Skeletal muscle and Duchenne muscular dystrophy.
His studies deal with areas such as Pediatrics and Weakness as well as Congenital myasthenic syndrome.
He most often published in these fields:
- Genetics (20.02%)
- Internal medicine (18.54%)
- Duchenne muscular dystrophy (14.59%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (18.54%)
- Disease (8.41%)
- Pediatrics (9.39%)
In recent papers he was focusing on the following fields of study:
Hanns Lochmüller mainly investigates Internal medicine, Disease, Pediatrics, Myotonic dystrophy and Duchenne muscular dystrophy.
Hanns Lochmüller focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Endocrinology and, in certain cases, Neuromuscular junction.
His work deals with themes such as Congenital myasthenic syndrome, Epidemiology and Cohort, which intersect with Pediatrics.
Hanns Lochmüller combines subjects such as Missense mutation, Muscle weakness and Weakness with his study of Congenital myasthenic syndrome.
His Missense mutation study necessitates a more in-depth grasp of Genetics.
His research investigates the connection with Duchenne muscular dystrophy and areas like Muscular dystrophy which intersect with concerns in Muscle disorder.
Between 2016 and 2021, his most popular works were:
- The Human Phenotype Ontology in 2017 (471 citations)
- Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. (276 citations)
- International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases. (157 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Mutation
The scientist’s investigation covers issues in Disease, Internal medicine, Duchenne muscular dystrophy, Pediatrics and Clinical trial.
His Disease research includes themes of Quality of life, Muscle weakness, MEDLINE and Bioinformatics.
His Internal medicine research includes elements of Endocrinology and Oncology.
Hanns Lochmüller usually deals with Endocrinology and limits it to topics linked to Acetylcholinesterase and Neuromuscular transmission.
His study in the field of Dystrophin also crosses realms of Cost-effectiveness analysis.
His Frameshift mutation study is associated with Genetics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
